Ht-Logo-gigapixel-icon
Thursday, December 12, 2024
Canada’s Politics and Government News Source Since 1989
Thursday, December 12, 2024 | Latest Paper

Chris Bonnett

Pharmacare bill offers too much ambiguity and too little ambition

Opinion | BY CHRIS BONNETT | April 10, 2024
Mark Holland
Health Minister Mark Holland has suggested the national pharmacare plan would initially cost about $1.5-billion annually, but that depends on the scope and pace of those bilateral agreements, writes Chris Bonnett. The Hill Times photograph by Andrew Meade
Opinion | BY CHRIS BONNETT | April 10, 2024
Opinion | BY CHRIS BONNETT | April 10, 2024
Mark Holland
Health Minister Mark Holland has suggested the national pharmacare plan would initially cost about $1.5-billion annually, but that depends on the scope and pace of those bilateral agreements, writes Chris Bonnett. The Hill Times photograph by Andrew Meade
Opinion | BY CHRIS BONNETT | April 10, 2024
Mark Holland
Health Minister Mark Holland has suggested the national pharmacare plan would initially cost about $1.5-billion annually, but that depends on the scope and pace of those bilateral agreements, writes Chris Bonnett. The Hill Times photograph by Andrew Meade
Opinion | BY CHRIS BONNETT | April 10, 2024
Opinion | BY CHRIS BONNETT | April 10, 2024
Mark Holland
Health Minister Mark Holland has suggested the national pharmacare plan would initially cost about $1.5-billion annually, but that depends on the scope and pace of those bilateral agreements, writes Chris Bonnett. The Hill Times photograph by Andrew Meade
Opinion | BY CHRIS BONNETT | September 13, 2023
NDP Leader Jagmeet Singh, pictured, is trying to leverage a national pharmacare program out of his party's supply-and-confidence agreement with the government. The NDP, and perhaps the Liberals, have just one model in mind: a fully public drug plan, writes Chris Bonnett. The Hill Times photograph by Andrew Meade
Opinion | BY CHRIS BONNETT | September 13, 2023
Opinion | BY CHRIS BONNETT | September 13, 2023
NDP Leader Jagmeet Singh, pictured, is trying to leverage a national pharmacare program out of his party's supply-and-confidence agreement with the government. The NDP, and perhaps the Liberals, have just one model in mind: a fully public drug plan, writes Chris Bonnett. The Hill Times photograph by Andrew Meade